Tag Archive for PRO/AH/EDR> Ebola update (51): funding, research, miscellaneous
PRO/AH/EDR> Ebola update (51): funding, research, miscellaneous
Ebola -- Worldwide/Unknown25 Jul 2016 Sierra Leone, New Guinea: Merck Ebola vaccine wins speedier reviews by regulatorsThe US Food and Drug Administration [FDA] granted a new therapy designation for the Merck vaccine, a status reserved for medicines designed to treat a serious or life-threatening illness, which will speed the approval process. At the same time, the European Medicines Agency granted the vaccine Prime status, which refers to a treatment targeting an unmet medical need.In addition, Read more [...]
